1973
DOI: 10.1073/pnas.70.7.1947
|View full text |Cite
|
Sign up to set email alerts
|

Stereospecific Binding of the Potent Narcotic Analgesic [ 3 H]Etorphine to Rat-Brain Homogenate

Abstract: Etorphine, the most potent narcotic analgesic known, was labeled with tritium by catalytic exchange. This drug exhibits stereospecific, saturable binding to rat-brain homogenate. At

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

5
209
0
8

Year Published

1978
1978
2007
2007

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 878 publications
(222 citation statements)
references
References 8 publications
5
209
0
8
Order By: Relevance
“…The distinct differences in the response to divalent cations and potencies of the various peptides and alkaloid in displacing the 3H-labeled ligands suggests a difference in the binding sites between f3-endorphin and enkephalin. This dissimilarity in the nature of these peptides' binding also suggests that rapid hydrolysis of enkephalin by brain homogenates (25) might not be the sole explanation for the lack of in vivo analgesic effect displayed by the pentapeptide (11,26). Although [D-Ala2 [Metlenkephalin had potent in vivo analgesic effect (27), the alteration in the secondary structure of the peptide (28) by the D amino acid could not be ignored.…”
Section: Methodsmentioning
confidence: 99%
“…The distinct differences in the response to divalent cations and potencies of the various peptides and alkaloid in displacing the 3H-labeled ligands suggests a difference in the binding sites between f3-endorphin and enkephalin. This dissimilarity in the nature of these peptides' binding also suggests that rapid hydrolysis of enkephalin by brain homogenates (25) might not be the sole explanation for the lack of in vivo analgesic effect displayed by the pentapeptide (11,26). Although [D-Ala2 [Metlenkephalin had potent in vivo analgesic effect (27), the alteration in the secondary structure of the peptide (28) by the D amino acid could not be ignored.…”
Section: Methodsmentioning
confidence: 99%
“…The theoretical underpinning to the action of opioid antagonists is that they interact with opioid receptors and compete with the opiate ligand. 9 In other words, when an opiate molecule enters the bloodstream, it circulates through the body until it comes into contact and binds with an opioid receptor, which [89], [104], [113]. Today we know that there are at least three sub-types of opioid receptor (dubbed µ-, δ-, and κ-opioid receptors), and the genes coding for them have been identified (on chromosomes 6, 1, and 8 in humans, respectively).…”
Section: Opiates and Opioidsmentioning
confidence: 99%
“…The discovery and characterization of opioid receptors in vertebrate brain was accomplished with the use of radioligand binding assays (Pert and Snyder, 1973;Simon et al, 1973;Terenius, 1973). Opioid receptors engaged opioid drugs in a stereoselective manner, and were found to be integral membrane proteins located predominantly in neurons.…”
Section: Introductionmentioning
confidence: 99%